Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Basic biomaterials research threatened by industry liability fears, AAAS panelists say.

This article was originally published in The Gray Sheet

Executive Summary

BASIC BIOMATERIALS RESEARCH IS THREATENED BY INDUSTRY'S LIABILITY FEARS, academic panelists maintained Feb. 19 at the American Association for the Advancement of Science annual meeting in Atlanta. "The industrial withdrawal from" biomaterials research and development "will eventually give us reduced manpower in the United States," said panelist James Anderson, Case Western Reserve University, Cleveland. "It already has had a major impact on industrial-academic collaborations in which research is carried out."

Latest Headlines
See All
UsernamePublicRestriction

Register

MT003504

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel